This review highlights that microalbuminuria is a common finding in diabetes and hypertension, serving as a marker for metabolic syndrome and a predictor of overt renal disease and increased mortality.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in diabetes and hypertension; leaves open whether microalbuminuria is a modifiable target in metabolic syndrome.
Microalbuminuria is defined in principle as abnormally increased albumin excretion below the level that is characteristic for proteinuria. In diabetes, microalbuminuria is defined as having an excretion rate of 20 to 200 µg/min. This level of albuminuria predicts overt renal disease in both non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus patients, and it is also associated with increased mortality. In nondiabetic individuals, the albumin excretion rate is not normally distributed with a skewed upper distribution. Excretion rate is lower during daytime, even during rest, than overnight. The median values in several studies for daytime and overnight albumin excretion rates are approximately 4 and 3 µg/min, respectively, with the upper 90th percentile approximately 15 and 10 µg/min, respectively. Microalbuminuria in population studies is significantly, but weakly, correlated to blood pressure, triglycerides, and low high-density lipoprotein cholesterol, as well as plasma glucose and obesity. These parameters are elements of the so-called metabolic syndrome. New studies in insulin-dependent diabetes mellitus on the transition from normo- to microalbuminuria show that high normal excretion rate and poor metabolic control are associated with progression. In non-insulin-dependent diabetes mellitus, microalbuminuria is quite common (20% to 25% of patients) in both newly diagnosed patients and patients with established diabetes. In many studies, a prevalence of approximately 20% is found, and again microalbuminuria is associated with components of the metabolic syndrome, which includes poor metabolic control and blood pressure elevation. In essential hypertension, microalbuminuria is also common (10% to 20%), although it is found with a prevalence that varies according to the level of blood pressure and the examined population, eg, the efficacy of antihypertensive treatment. This paper will review studies related to epidemiology of microalbuminuria in the population and among diabetics, but provides only short notes on patients with essential hypertension.
No takes yet. Share an insight, caveat, or question.
Mogensen et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: